A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs

From concept to clinical trial

M. Adelaide Asnaghi, Philipp Jungebluth, Manuela T. Raimondi, Sally C. Dickinson, Louisa E N Rees, Tetsuhiko Go, Tristan A. Cogan, Amanda Dodson, Pier Paolo Parnigotto, Anthony P. Hollander, Martin A. Birchall, Maria Teresa Conconi, Paolo Macchiarini, Sara Mantero

Research output: Contribution to journalArticle

76 Citations (Scopus)

Abstract

Cell and tissue engineering are now being translated into clinical organ replacement, offering alternatives to fight morbidity, organ shortages and ethico-social problems associated with allotransplantation. Central to the recent first successful use of stem cells to create an organ replacement in man was our development of a bioreactor environment. Critical design features were the abilities to drive the growth of two different cell types, to support 3D maturation, to maintain biomechanical and biological properties and to provide appropriate hydrodynamic stimuli and adequate mass transport. An analytical model was developed and applied to predict oxygen profiles in the bioreactor-cultured organ construct and in the culture media, comparing representative culture configurations and operating conditions. Autologous respiratory epithelial cells and mesenchymal stem cells (BMSCs, then differentiated into chondrocytes) were isolated, characterized and expanded. Both cell types were seeded and cultured onto a decellularized human donor tracheal matrix within the bioreactor. One year post-operatively, graft and patient are healthy, and biopsies confirm angiogenesis, viable epithelial cells and chondrocytes. Our rotating double-chamber bioreactor permits the efficient repopulation of a decellularized human matrix, a concept that can be applied clinically, as demonstrated by the successful tracheal transplantation.

Original languageEnglish (US)
Pages (from-to)5260-5269
Number of pages10
JournalBiomaterials
Volume30
Issue number29
DOIs
StatePublished - Oct 2009
Externally publishedYes

Fingerprint

Bioreactors
Clinical Trials
Tissue
Chondrocytes
Stem cells
Cell engineering
Epithelial Cells
Cell Engineering
Biopsy
Social Problems
Hydrodynamics
Tissue Engineering
Mesenchymal Stromal Cells
Tissue engineering
Grafts
Culture Media
Analytical models
Stem Cells
Mass transfer
Transplantation

Keywords

  • Airway transplantation
  • Bioreactor
  • Co-culture
  • Oxygenation
  • Stem cells
  • Tissue engineering

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Asnaghi, M. A., Jungebluth, P., Raimondi, M. T., Dickinson, S. C., Rees, L. E. N., Go, T., ... Mantero, S. (2009). A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: From concept to clinical trial. Biomaterials, 30(29), 5260-5269. https://doi.org/10.1016/j.biomaterials.2009.07.018

A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs : From concept to clinical trial. / Asnaghi, M. Adelaide; Jungebluth, Philipp; Raimondi, Manuela T.; Dickinson, Sally C.; Rees, Louisa E N; Go, Tetsuhiko; Cogan, Tristan A.; Dodson, Amanda; Parnigotto, Pier Paolo; Hollander, Anthony P.; Birchall, Martin A.; Conconi, Maria Teresa; Macchiarini, Paolo; Mantero, Sara.

In: Biomaterials, Vol. 30, No. 29, 10.2009, p. 5260-5269.

Research output: Contribution to journalArticle

Asnaghi, MA, Jungebluth, P, Raimondi, MT, Dickinson, SC, Rees, LEN, Go, T, Cogan, TA, Dodson, A, Parnigotto, PP, Hollander, AP, Birchall, MA, Conconi, MT, Macchiarini, P & Mantero, S 2009, 'A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: From concept to clinical trial', Biomaterials, vol. 30, no. 29, pp. 5260-5269. https://doi.org/10.1016/j.biomaterials.2009.07.018
Asnaghi, M. Adelaide ; Jungebluth, Philipp ; Raimondi, Manuela T. ; Dickinson, Sally C. ; Rees, Louisa E N ; Go, Tetsuhiko ; Cogan, Tristan A. ; Dodson, Amanda ; Parnigotto, Pier Paolo ; Hollander, Anthony P. ; Birchall, Martin A. ; Conconi, Maria Teresa ; Macchiarini, Paolo ; Mantero, Sara. / A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs : From concept to clinical trial. In: Biomaterials. 2009 ; Vol. 30, No. 29. pp. 5260-5269.
@article{6b13644ce723478bae191fd9270737e3,
title = "A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs: From concept to clinical trial",
abstract = "Cell and tissue engineering are now being translated into clinical organ replacement, offering alternatives to fight morbidity, organ shortages and ethico-social problems associated with allotransplantation. Central to the recent first successful use of stem cells to create an organ replacement in man was our development of a bioreactor environment. Critical design features were the abilities to drive the growth of two different cell types, to support 3D maturation, to maintain biomechanical and biological properties and to provide appropriate hydrodynamic stimuli and adequate mass transport. An analytical model was developed and applied to predict oxygen profiles in the bioreactor-cultured organ construct and in the culture media, comparing representative culture configurations and operating conditions. Autologous respiratory epithelial cells and mesenchymal stem cells (BMSCs, then differentiated into chondrocytes) were isolated, characterized and expanded. Both cell types were seeded and cultured onto a decellularized human donor tracheal matrix within the bioreactor. One year post-operatively, graft and patient are healthy, and biopsies confirm angiogenesis, viable epithelial cells and chondrocytes. Our rotating double-chamber bioreactor permits the efficient repopulation of a decellularized human matrix, a concept that can be applied clinically, as demonstrated by the successful tracheal transplantation.",
keywords = "Airway transplantation, Bioreactor, Co-culture, Oxygenation, Stem cells, Tissue engineering",
author = "Asnaghi, {M. Adelaide} and Philipp Jungebluth and Raimondi, {Manuela T.} and Dickinson, {Sally C.} and Rees, {Louisa E N} and Tetsuhiko Go and Cogan, {Tristan A.} and Amanda Dodson and Parnigotto, {Pier Paolo} and Hollander, {Anthony P.} and Birchall, {Martin A.} and Conconi, {Maria Teresa} and Paolo Macchiarini and Sara Mantero",
year = "2009",
month = "10",
doi = "10.1016/j.biomaterials.2009.07.018",
language = "English (US)",
volume = "30",
pages = "5260--5269",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "29",

}

TY - JOUR

T1 - A double-chamber rotating bioreactor for the development of tissue-engineered hollow organs

T2 - From concept to clinical trial

AU - Asnaghi, M. Adelaide

AU - Jungebluth, Philipp

AU - Raimondi, Manuela T.

AU - Dickinson, Sally C.

AU - Rees, Louisa E N

AU - Go, Tetsuhiko

AU - Cogan, Tristan A.

AU - Dodson, Amanda

AU - Parnigotto, Pier Paolo

AU - Hollander, Anthony P.

AU - Birchall, Martin A.

AU - Conconi, Maria Teresa

AU - Macchiarini, Paolo

AU - Mantero, Sara

PY - 2009/10

Y1 - 2009/10

N2 - Cell and tissue engineering are now being translated into clinical organ replacement, offering alternatives to fight morbidity, organ shortages and ethico-social problems associated with allotransplantation. Central to the recent first successful use of stem cells to create an organ replacement in man was our development of a bioreactor environment. Critical design features were the abilities to drive the growth of two different cell types, to support 3D maturation, to maintain biomechanical and biological properties and to provide appropriate hydrodynamic stimuli and adequate mass transport. An analytical model was developed and applied to predict oxygen profiles in the bioreactor-cultured organ construct and in the culture media, comparing representative culture configurations and operating conditions. Autologous respiratory epithelial cells and mesenchymal stem cells (BMSCs, then differentiated into chondrocytes) were isolated, characterized and expanded. Both cell types were seeded and cultured onto a decellularized human donor tracheal matrix within the bioreactor. One year post-operatively, graft and patient are healthy, and biopsies confirm angiogenesis, viable epithelial cells and chondrocytes. Our rotating double-chamber bioreactor permits the efficient repopulation of a decellularized human matrix, a concept that can be applied clinically, as demonstrated by the successful tracheal transplantation.

AB - Cell and tissue engineering are now being translated into clinical organ replacement, offering alternatives to fight morbidity, organ shortages and ethico-social problems associated with allotransplantation. Central to the recent first successful use of stem cells to create an organ replacement in man was our development of a bioreactor environment. Critical design features were the abilities to drive the growth of two different cell types, to support 3D maturation, to maintain biomechanical and biological properties and to provide appropriate hydrodynamic stimuli and adequate mass transport. An analytical model was developed and applied to predict oxygen profiles in the bioreactor-cultured organ construct and in the culture media, comparing representative culture configurations and operating conditions. Autologous respiratory epithelial cells and mesenchymal stem cells (BMSCs, then differentiated into chondrocytes) were isolated, characterized and expanded. Both cell types were seeded and cultured onto a decellularized human donor tracheal matrix within the bioreactor. One year post-operatively, graft and patient are healthy, and biopsies confirm angiogenesis, viable epithelial cells and chondrocytes. Our rotating double-chamber bioreactor permits the efficient repopulation of a decellularized human matrix, a concept that can be applied clinically, as demonstrated by the successful tracheal transplantation.

KW - Airway transplantation

KW - Bioreactor

KW - Co-culture

KW - Oxygenation

KW - Stem cells

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=68549128478&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68549128478&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2009.07.018

DO - 10.1016/j.biomaterials.2009.07.018

M3 - Article

VL - 30

SP - 5260

EP - 5269

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 29

ER -